What is Habit?
Habit operates at the intersection of biotechnology and consumer wellness, providing a sophisticated platform that eliminates the ambiguity often associated with dietary planning. By utilizing comprehensive at-home diagnostic testing, the company synthesizes genetic markers, metabolic profiles, and lifestyle data to generate bespoke nutritional guidance. This personalized approach represents a departure from traditional, generalized diet models, positioning Habit as a leader in the burgeoning field of precision health. The company's ability to translate complex biological insights into actionable, daily eating recommendations provides a distinct competitive advantage in a market increasingly focused on data-backed health optimization.
How much funding has Habit raised?
Habit has raised a total of $32M across 1 funding round:
Unspecified
$32M
Unspecified (2016): $32M, investors not publicly disclosed
Key Investors in Habit
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Habit?
With this major enterprise-level funding, Habit is poised to accelerate its operational growth and refine its proprietary recommendation engine. The strategic deployment of this capital will likely focus on enhancing the scalability of its diagnostic supply chain and deepening its research capabilities to incorporate broader health metrics. As the company transitions into its next phase of development, the focus will shift toward market penetration and the integration of its personalized nutrition insights into broader digital health ecosystems. Investors are closely watching how Habit will leverage this financial backing to solidify its market share and establish long-term partnerships within the healthcare and wellness industries.
See full Habit company page
